One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2021-148451
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 7 |
Affiliation: Peter MacCallum Cancer Centre, Royal Melbourne Hospital, University of Melbourne, St Vincent's Hospital, Concord Repatriation General Hospital, University of Sydney, Canossa Private Hospital, Auckland City Hospital, Massachusetts General Hospital, BeiGene (China), Monash University, Monash Health, Sir Charles Gairdner Hospital, University of Western AustraliaPreliminary Safety and Efficacy Data from Patients (Pts) with Relapsed/Refractory (R/R) B-Cell Malignancies Treated with the Novel B-Cell Lymphoma 2 (BCL2) Inhibitor BGB-11417 in Monotherapy or in Combination with Zanubrutinib
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
